We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+765.1%
AUM
$134B
AUM Growth
-$11B
(-7.6%)
Cap. Flow
-$13.8B
Cap. Flow
% of AUM
-10.25%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
2,770
New
225
Increased
999
Reduced
863
Closed
385
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$572M |
| 2 |
Palo Alto Networks
PANW
|
+$334M |
| 3 |
Enphase Energy
ENPH
|
+$309M |
| 4 |
Devon Energy
DVN
|
+$309M |
| 5 |
Cisco
CSCO
|
+$298M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Noble Corp
NE
|
+$763M |
| 2 |
SLB Ltd
SLB
|
+$419M |
| 3 |
Amazon
AMZN
|
+$371M |
| 4 |
Meta Platforms (Facebook)
META
|
+$360M |
| 5 |
Twilio
TWLO
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.34% |
| 2 | Healthcare | 10.52% |
| 3 | Consumer Discretionary | 9.22% |
| 4 | Financials | 7.69% |
| 5 | Industrials | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
CALL
Moderna
MRNA
$25.4B
| $1.26M | ﹤0.01% |
7,300
+5,700
| +356% | +$960K |
|
1627
TTEC Holdings
TTEC
$77.4M
| $1.26M | ﹤0.01% |
15,230
-3,516
| -19% | -$282K |
|
1628
PUT
Microchip Technology
MCHP
$42.4B
| $1.25M | ﹤0.01% |
16,700
-7,100
| -30% | -$535K |
|
|
RXDX
1629
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.25M | ﹤0.01% |
33,135
+22,065
| +199% | +$872K |
|
1630
PUT
Zoetis
ZTS
$31.2B
| $1.25M | ﹤0.01% |
6,600
-5,600
| -46% | -$1.11M |
|
|
MRTX
1631
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.24M | ﹤0.01% |
15,115
-8,312
| -35% | -$850K |
|
1632
Celldex Therapeutics
CLDX
$3.37B
| $1.23M | ﹤0.01% |
36,205
| – | – |
|
1633
Deluxe
DLX
$1.12B
| $1.23M | ﹤0.01% |
40,742
+8,881
| +28% | +$279K |
|
1634
Stanley Black & Decker
SWK
$15.4B
| $1.22M | ﹤0.01% |
8,711
+629
| +8% | +$104K |
|
1635
Aura Biosciences
AURA
$792M
| $1.21M | ﹤0.01% |
55,145
| – | – |
|
1636
Karyopharm Therapeutics
KPTI
$44.9M
| $1.21M | ﹤0.01% |
10,932
-1,541
| -12% | -$192K |
|
1637
CALL
Northrop Grumman
NOC
$81.7B
| $1.21M | ﹤0.01% |
+2,700
| New | +$1.11M |
|
1638
PUT
Becton Dickinson
BDX
$49.6B
| $1.2M | ﹤0.01% |
4,613
-3,280
| -42% | -$845K |
|
1639
ChargePoint
CHPT
$160M
| $1.19M | ﹤0.01% |
3,000
| – | – |
|
1640
Unilever
UL
$135B
| $1.19M | ﹤0.01% |
23,140
+7,018
| +44% | +$391K |
|
|
LILMW
1641
DELISTED
Lilium N.V. Warrants
LILMW
| $1.19M | ﹤0.01% |
1,765,000
-1,088,997
| -38% | -$818K |
|
1642
Adicet Bio
ACET
$77.3M
| $1.18M | ﹤0.01% |
3,701
+1,271
| +52% | +$292K |
|
1643
Victory Capital Holdings
VCTR
$7.22B
| $1.18M | ﹤0.01% |
+40,911
| New | +$1.34M |
|
|
MDRX
1644
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.18M | ﹤0.01% |
52,425
+11,551
| +28% | +$234K |
|
|
FOE
1645
DELISTED
Ferro Corporation
FOE
| $1.18M | ﹤0.01% |
54,300
| – | – |
|
|
SWTX
1646
DELISTED
SpringWorks Therapeutics
SWTX
| $1.18M | ﹤0.01% |
20,851
-4,394
| -17% | -$251K |
|
1647
CoStar Group
CSGP
$13.3B
| $1.17M | ﹤0.01% |
17,549
-14,483
| -45% | -$962K |
|
|
PSTH
1648
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $1.16M | ﹤0.01% |
58,500
| – | – |
|
|
BURU
1649
DELISTED
NUBURU INC
BURU
| $1.16M | ﹤0.01% |
586
| – | – |
|
1650
Cal-Maine
CALM
$3.9B
| $1.16M | ﹤0.01% |
20,969
+241
| +1% | +$10.5K |
|
Similar funds
Allianz Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Allianz Asset Management held 2,770 positions worth $134B, down 7.6% from $145B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Allianz Asset Management withdrew a net $13.8B in Q1 2022, closing 385 positions and reducing 863 holdings. Its most notable exit was Mandiant, Inc. Common Stock, an estimated $246M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Allianz Asset Management opened a new position in SiteOne Landscape Supply worth $93M.
- Allianz Asset Management's largest Q1 2022 buy was SiteOne Landscape Supply: 575,233 shares worth $93M.
- Allianz Asset Management added most to NVIDIA in Q1 2022, an estimated $572M increase.
- Allianz Asset Management's biggest Q1 2022 reduction was Noble Corp, cutting an estimated $763M.
- Allianz Asset Management fully exited Mandiant, Inc. Common Stock in Q1 2022, selling an estimated $246M.
- Allianz Asset Management's ten largest holdings make up 18% of its $134B portfolio in Q1 2022.
- Allianz Asset Management opened 225 new positions and closed 385 in Q1 2022.
- Allianz Asset Management's portfolio value fell 7.6% quarter-over-quarter to $134B.
Based on Allianz Asset Management's 13F filing for Q1 2022, filed 13 May 2022.